Clinical results of radiation therapy for stage I esophageal cancer: A single institutional experience

Yoshiyuki Shioyama, Katsumasa Nakamura, Tomonari Sasaki, Saiji Ooga, Yusuke Urashima, Masahiko Kimura, Satoru Uehara, Hiromi Terashima, Hiroshi Honda

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

From 1992 through 2001, 29 patients with stage I esophageal cancer were treated with radiation therapy. All patients had squamous cell carcinoma. Seventeen patients were treated with radiotherapy alone, and 12 were treated with a combination of chemotherapy and radiotherapy. Most of the chemotherapy regimens included cisplatin and/or 5-fluorouracil (5-FU). Twelve patients were treated with intracavitary irradiation (low-dose rate: 6, high-dose rate: 6) after external radiotherapy. Median fraction and total doses of external radiotherapy given were 2.0 Gy and 60.6 Gy, respectively. Median doses of intracavitary irradiation were 18 Gy/6 fractions in low-dose-rate brachytherapy and 13.5 Gy/4.5 fractions in high-dose-rate brachytherapy. The 5-year overall survival rate was 62%. The 5-year local control rate was 44%. Of the 29 patients, 9 had in-field recurrence in the esophagus and 1 had recurrence in the esophagus outside of the irradiated field. Of 9 patients with in-field local recurrence, 1 also developed mediastinal lymph node metastases and 1 had distant metastasis. Radiation therapy is an effective treatment modality for stage I esophageal cancer.

Original languageEnglish
Pages (from-to)75-80
Number of pages6
JournalAmerican Journal of Clinical Oncology: Cancer Clinical Trials
Volume28
Issue number1
DOIs
Publication statusPublished - Feb 1 2005

Fingerprint

Esophageal Neoplasms
Radiotherapy
Brachytherapy
Recurrence
Esophagus
Neoplasm Metastasis
Combination Drug Therapy
Fluorouracil
Cisplatin
Squamous Cell Carcinoma
Survival Rate
Lymph Nodes
Drug Therapy

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Clinical results of radiation therapy for stage I esophageal cancer : A single institutional experience. / Shioyama, Yoshiyuki; Nakamura, Katsumasa; Sasaki, Tomonari; Ooga, Saiji; Urashima, Yusuke; Kimura, Masahiko; Uehara, Satoru; Terashima, Hiromi; Honda, Hiroshi.

In: American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 28, No. 1, 01.02.2005, p. 75-80.

Research output: Contribution to journalArticle

Shioyama, Yoshiyuki ; Nakamura, Katsumasa ; Sasaki, Tomonari ; Ooga, Saiji ; Urashima, Yusuke ; Kimura, Masahiko ; Uehara, Satoru ; Terashima, Hiromi ; Honda, Hiroshi. / Clinical results of radiation therapy for stage I esophageal cancer : A single institutional experience. In: American Journal of Clinical Oncology: Cancer Clinical Trials. 2005 ; Vol. 28, No. 1. pp. 75-80.
@article{1e5504ec378a45cdac4b02f4fde797e0,
title = "Clinical results of radiation therapy for stage I esophageal cancer: A single institutional experience",
abstract = "From 1992 through 2001, 29 patients with stage I esophageal cancer were treated with radiation therapy. All patients had squamous cell carcinoma. Seventeen patients were treated with radiotherapy alone, and 12 were treated with a combination of chemotherapy and radiotherapy. Most of the chemotherapy regimens included cisplatin and/or 5-fluorouracil (5-FU). Twelve patients were treated with intracavitary irradiation (low-dose rate: 6, high-dose rate: 6) after external radiotherapy. Median fraction and total doses of external radiotherapy given were 2.0 Gy and 60.6 Gy, respectively. Median doses of intracavitary irradiation were 18 Gy/6 fractions in low-dose-rate brachytherapy and 13.5 Gy/4.5 fractions in high-dose-rate brachytherapy. The 5-year overall survival rate was 62{\%}. The 5-year local control rate was 44{\%}. Of the 29 patients, 9 had in-field recurrence in the esophagus and 1 had recurrence in the esophagus outside of the irradiated field. Of 9 patients with in-field local recurrence, 1 also developed mediastinal lymph node metastases and 1 had distant metastasis. Radiation therapy is an effective treatment modality for stage I esophageal cancer.",
author = "Yoshiyuki Shioyama and Katsumasa Nakamura and Tomonari Sasaki and Saiji Ooga and Yusuke Urashima and Masahiko Kimura and Satoru Uehara and Hiromi Terashima and Hiroshi Honda",
year = "2005",
month = "2",
day = "1",
doi = "10.1097/01.coc.0000139021.91718.ee",
language = "English",
volume = "28",
pages = "75--80",
journal = "American Journal of Clinical Oncology",
issn = "0277-3732",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Clinical results of radiation therapy for stage I esophageal cancer

T2 - A single institutional experience

AU - Shioyama, Yoshiyuki

AU - Nakamura, Katsumasa

AU - Sasaki, Tomonari

AU - Ooga, Saiji

AU - Urashima, Yusuke

AU - Kimura, Masahiko

AU - Uehara, Satoru

AU - Terashima, Hiromi

AU - Honda, Hiroshi

PY - 2005/2/1

Y1 - 2005/2/1

N2 - From 1992 through 2001, 29 patients with stage I esophageal cancer were treated with radiation therapy. All patients had squamous cell carcinoma. Seventeen patients were treated with radiotherapy alone, and 12 were treated with a combination of chemotherapy and radiotherapy. Most of the chemotherapy regimens included cisplatin and/or 5-fluorouracil (5-FU). Twelve patients were treated with intracavitary irradiation (low-dose rate: 6, high-dose rate: 6) after external radiotherapy. Median fraction and total doses of external radiotherapy given were 2.0 Gy and 60.6 Gy, respectively. Median doses of intracavitary irradiation were 18 Gy/6 fractions in low-dose-rate brachytherapy and 13.5 Gy/4.5 fractions in high-dose-rate brachytherapy. The 5-year overall survival rate was 62%. The 5-year local control rate was 44%. Of the 29 patients, 9 had in-field recurrence in the esophagus and 1 had recurrence in the esophagus outside of the irradiated field. Of 9 patients with in-field local recurrence, 1 also developed mediastinal lymph node metastases and 1 had distant metastasis. Radiation therapy is an effective treatment modality for stage I esophageal cancer.

AB - From 1992 through 2001, 29 patients with stage I esophageal cancer were treated with radiation therapy. All patients had squamous cell carcinoma. Seventeen patients were treated with radiotherapy alone, and 12 were treated with a combination of chemotherapy and radiotherapy. Most of the chemotherapy regimens included cisplatin and/or 5-fluorouracil (5-FU). Twelve patients were treated with intracavitary irradiation (low-dose rate: 6, high-dose rate: 6) after external radiotherapy. Median fraction and total doses of external radiotherapy given were 2.0 Gy and 60.6 Gy, respectively. Median doses of intracavitary irradiation were 18 Gy/6 fractions in low-dose-rate brachytherapy and 13.5 Gy/4.5 fractions in high-dose-rate brachytherapy. The 5-year overall survival rate was 62%. The 5-year local control rate was 44%. Of the 29 patients, 9 had in-field recurrence in the esophagus and 1 had recurrence in the esophagus outside of the irradiated field. Of 9 patients with in-field local recurrence, 1 also developed mediastinal lymph node metastases and 1 had distant metastasis. Radiation therapy is an effective treatment modality for stage I esophageal cancer.

UR - http://www.scopus.com/inward/record.url?scp=13444260748&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13444260748&partnerID=8YFLogxK

U2 - 10.1097/01.coc.0000139021.91718.ee

DO - 10.1097/01.coc.0000139021.91718.ee

M3 - Article

C2 - 15685039

AN - SCOPUS:13444260748

VL - 28

SP - 75

EP - 80

JO - American Journal of Clinical Oncology

JF - American Journal of Clinical Oncology

SN - 0277-3732

IS - 1

ER -